Deep Brain Stimulators (DBS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Deep Brain Stimulators (DBS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Deep Brain Stimulators (DBS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Deep Brain Stimulators (DBS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A Deep Brain Stimulators (DBS) is a device that is comprised of a brain-oriented pacemaker (an implantable pulse generator) that sends electrical stimulation through surgically implanted electrodes to specific targets in the brain. DBSs are commonly used to treat movement disorders as well as neuropsychiatric disorders.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Deep Brain Stimulators (DBS) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Deep Brain Stimulators (DBS) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Deep Brain Stimulators (DBS) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Deep Brain Stimulators (DBS) Overview
Products under Development
Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Table Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Table Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Deep Brain Stimulators (DBS) - Pipeline Products by Segment
Table Deep Brain Stimulators (DBS) - Pipeline Products by Segment
Table Deep Brain Stimulators (DBS) - Pipeline Products by Segment
Deep Brain Stimulators (DBS) - Pipeline Products by Territory
Table Deep Brain Stimulators (DBS) - Pipeline Products by Territory
Table Deep Brain Stimulators (DBS) - Pipeline Products by Territory
Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
Table Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
Table Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
Table Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
Table Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
Table Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
Table Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
Deep Brain Stimulators (DBS) - Pipeline Products under Development by Companies
Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
Table Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Table Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Deep Brain Stimulators (DBS) Companies and Product Overview
Table Deep Brain Stimulation System - Alzheimer's Disease - Product Status
Table Deep Brain Stimulation System - Alzheimer's Disease - Product Description
Table Deep Brain Stimulation System - Obesity - Product Status
Table Deep Brain Stimulation System - Obesity - Product Description
Table Deep Brain Stimulation System - Opioid Addiction - Product Status
Table Deep Brain Stimulation System - Opioid Addiction - Product Description
Table Allegheny Health Network - Ongoing Clinical Trials Overview
Table Deep Brain Stimulation System - Opioid Addiction - Pilot Study to Evaluate Deep Brain Stimulation (DBS) of the Nucleus Accumbens (NAc) for Patients with Treatment-refractory Opioid Use Disorder
Table Enspire DBS Therapy System - Rehab With Electrical Stimulation Therapy to Optimize Rehabilitation Effect (RESTORE): A Pivotal Study
Hangzhou General Stim Biotechnology Co Ltd Company Overview
Hangzhou General Stim Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Hangzhou General Stim Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Dual-Channel Implantable Deep Brain Stimulation System - Product Status
Table Dual-Channel Implantable Deep Brain Stimulation System - Product Description
Table Hangzhou General Stim Biotechnology Co Ltd - Ongoing Clinical Trials Overview
Table Dual-Channel Implantable Deep Brain Stimulation System - A Prospective, Multi-center, Blinded, Randomized Controlled Clinical Trial Evaluating the Safety and Efficacy of a Dual-channel Implantable Deep Brain Stimulation System for Improving Clinical Symptoms of Parkinson's Disease
Hangzhou Promise Medical Technology Co Ltd Company Overview
Hangzhou Promise Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Hangzhou Promise Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Deep Brain Neurostimulation System - Product Status
Table Deep Brain Neurostimulation System - Product Description
Louisiana State University Company Overview
Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview
Table Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview
Table Wireless Implantable Neural Stimulator - Product Status
Table AlphaDBS - A Double-blind Crossover Study to Evaluate the Safety and Efficacy of Adaptive Deep Brain Stimulation Delivered through AlphaDBS System in Patients with Parkinson's Disease
Sunnybrook Health Sciences Centre Company Overview
Sunnybrook Health Sciences Centre Pipeline Products & Ongoing Clinical Trials Overview
Table Sunnybrook Health Sciences Centre Pipeline Products & Ongoing Clinical Trials Overview
Table Deep Brain Stimulation Device - PTSD - Product Status
Table Deep Brain Stimulation Device - PTSD - Product Description
Table Sunnybrook Health Sciences Centre - Ongoing Clinical Trials Overview
Table Deep Brain Stimulation Device - PTSD - Deep Brain Stimulation (DBS) for the Treatment of Refractory Post-traumatic Stress Disorder (PTSD): Pilot Trial
UConn School of Medicine Company Overview
UConn School of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table UConn School of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table Deep Brain Stimulator - Product Status
Table Deep Brain Stimulator - Product Description
University of California Los Angeles Company Overview
University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
Table University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
Table Deep Brain Stimulation Device - Product Status
Table Deep Brain Stimulation Device - Product Description
Table Implantable Ultrasound Neuromodulation Device - Product Status
University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
Table University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
Table Deep Brain Stimulation Device - Seizures - Product Status
Table Deep Brain Stimulation Device - Seizures - Product Description
University of Rochester Company Overview
University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
Table University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
Table Deep Brain Magnetic Stimulator - Product Status
Table Deep Brain Magnetic Stimulator - Product Description
University of South Florida Company Overview
University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
Table University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
Table Deep Brain Stimulator - Product Status
Table Deep Brain Stimulator - Product Description
Deep Brain Stimulators (DBS)- Recent Developments
Aug 20, 2024: Self-Adjusting Brain Pacemaker May Help Reduce Parkinson's Disease Symptoms
Aug 19, 2024: Taming Parkinson's Disease with Intelligent Brain Pacemakers
Aug 15, 2024: NIH Funds UK's Groundbreaking DBS-Plus Trial for Parkinson's
Aug 12, 2024: Medtronic Receives Landmark FDA Approval for Asleep Deep Brain Stimulation Surgery
Aug 04, 2024: Medtronic Receives Humanitarian Device Exemption (HDE) For Percept RC With BrainSense
Jul 15, 2024: Medtronic Neuromodulation Receives Humanitarian Device Exemption (HDE) For Percept PC BrainSense Neurostimulator Model - B35200
Jul 15, 2024: Medtronic Receives Humanitarian Device Exemption For Reclaim DBS System
Jul 15, 2024: Medtronic Neuromodulation Receives Humanitarian Device Exemption (HDE) For Activa Dystonia Therapy System
Jul 10, 2024: Medtronic Receives Humanitarian Device Exemption (Hde) For Reclaim DBS System
Jul 10, 2024: Medtronic Neuromodulation Receives Additional Humanitarian Device Exemption (HDE) Clearance for Percept PC BrainSense Neurostimulator Model - B35200
Jul 10, 2024: Medtronic Neuromodulation Obtains Additional Humanitarian Device Exemption (HDE) Clearance for the Activa Dystonia Therapy System
Jun 18, 2024: New Technology Allows Researchers to Precisely, Flexibly Modulate Brain
Jun 13, 2024: Nexalin Technology Announces Regulatory Approval to Sell Nexalin's Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
Jun 13, 2024: Medtronic Confirms Global Layoffs
Jun 06, 2024: Medtronic Neuromodulation obtains Additional Humanitarian Device Exemption (HDE) clearance for Activa Dystonia Therapy System
May 16, 2024: Medtronic Neuromodulation Receives Additional 510(K) Clearance For Percept PC BrainSense Neurostimulator Model - B35200
May 13, 2024: Medtronic Neuromodulation receives additional 510(k) clearance for Activa Dystonia Therapy System
May 08, 2024: Medtronic Neuromodulation Receives Additional Humanitarian Device Exemption (HDE) clearance for Activa Dystonia Therapy System
May 08, 2024: Medtronic Receive Additional Humanitarian Device Exemption (HDE) clearance for Reclaim DBS System
May 08, 2024: Medtronic Receives Additional Humanitarian Device Exemption (HDE) clearance for Percept PC Neurostimulator DBS System
Apr 23, 2024: Medtronic Neuromodulation Receives Additional Humanitarian Device Exemption (HDE) Clearance for Activa Dystonia Therapy System
Apr 23, 2024: Medtronic ) Receives Humanitarian Device Exemption (HDE) for Percept RC With BrainSense
Apr 15, 2024: Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Apr 12, 2024: Rice team demonstrates miniature brain stimulator in humans
Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
Mar 04, 2024: Medtronic Neuromodulation Receives Additional Humanitarian Device Exemption (HDE) For Activa Dystonia Therapy System
Mar 04, 2024: Medtronic Receives Additional Humanitarian Device Exemption (HDE) For Reclaim DBS System
Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
Feb 15, 2024: Stephen Agostini Named UCLA's Vice Chancellor and Chief Financial Officer
Feb 14, 2024: UT Health San Antonio doctors among first to implant rechargeable deep brain stimulation device
Jan 28, 2024: Medtronic Receives An Additional HDE Clearance for Reclaim DBS System
Jan 26, 2024: Abbott scores FDA approval for small, long lasting rechargeable DBS
Jan 11, 2024: AHN Team Performs Region's First Deep Brain Stimulation Therapy to Treat Opioid Addiction
Jan 11, 2024: Nexalin Technology Unveils Next-Generation HALO Clarity
Jan 09, 2024: US FDA approves Medtronic's Percept RC neurostimulator
Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
Dec 05, 2023: Medtronic Receives CE Mark for the Percept RC Rechargeable DBS Neurostimulator With BrainSense Technology
Dec 04, 2023: NeuroPace to Leverage the Power of its RNS System's Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
Dec 04, 2023: UCF Welcomes Alum and Distinguished Military Leader as Associate VP of Federal Affairs
Nov 16, 2023: Neuroone Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
Nov 02, 2023: Medtronic Obtains Additional Humanitarian Device Exemption (HDE) Clearance for Activa Dystonia Therapy System
Nov 02, 2023: Medtronic Receives Additional HDE Clearance for Reclaim DBS System
Nov 02, 2023: Medtronic Neuromodulation Receives Additional HDE Clearance for Percept PC BrainSense
Nov 02, 2023: Medtronic Neuromodulation Receives Additional HDE Clearance for Percept PC BrainSense
Oct 17, 2023: NeuroPace Announces RNS System Enhancements Designed to Streamline Care
Oct 12, 2023: Medtronic Neuromodulation Obtains Additional Humanitarian Device Exemption (HDE) Clearance for Percept PC BrainSense
Oct 12, 2023: Medtronic Obtains Additional Humanitarian Device Exemption (HDE) Clearance for Activa Dystonia Therapy System
Sep 07, 2023: UCF Names Saiful Khondaker as Interim Assistant Vice President for Research Advancement